Skip to content
Policy Hub Login
WHG-logo-170
whg-logo
Policy Hub Login
  • About Us
    • Mission & Values
    • Our Experts
    • Social Responsibility
    • WHG in the News
    • Black Lives Matter
    • Supporting AAPI Communities
  • What We Do
    • Policy Hub
    • State Policy Hub
    • Advisory
    • Influence
    • Knowledge
    • Public Relations
    • Grant Writing
  • Who We Serve
  • Knowledge Bank
    • Latest Analysis
    • WynneSights Blog
    • Thought Leadership
    • ACA NOW
  • Get In Touch

The Drug Pricing Debate Part II: The Many Acts of Congress

By Billy Wynne | August 10, 2019

Recent Posts

  • Agency Seeks Six Nominees for Advisory Committee on Minority Health; Due Mar. 4, 2021 December 4, 2020
  • CY 2021 MPFS Final Rule Finalizes Permanent Expansion of Certain COVID-19 Telehealth Flexibilities; Also Includes Changes to QPP, E/M Code Valuation, and Providers’ Scope of Practice December 2, 2020
  • Agency Requests Information About COVID-19 Regulatory Flexibilities to Inform Permanent Changes; Comments Due Dec. 25 December 1, 2020
  • OIG Follows Through on Rule Removing Safe Harbor Protection for Drug Rebates in Medicare Part D and Medicaid MCOs Beginning in 2022; New Safe Harbors for Point-of-Sale Discounts, PBM Services Fees Available in 60 Days November 20, 2020

Categories

  • No categories

CONTACT US

Improving Health is Our Policy

Complimentary Consultation
Free Newsletter

(202) 309-0796 |   administrator@wynnehealth.com

Wynne Health Group Locations

States 2021
Wynne Health Group Logo

About Us | What We Do | Who We Serve | Knowledge Bank | Get In Touch

© 2020 Wynne Health. All Rights Reserved.